We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
All companies within the health care industry should be aware of two recent developments in the area of medical device approval and federal health care program reimbursement
